Compare ANTX & AACG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ANTX | AACG |
|---|---|---|
| Founded | 2017 | 1999 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.2M | 35.3M |
| IPO Year | 2022 | N/A |
| Metric | ANTX | AACG |
|---|---|---|
| Price | $1.16 | $1.13 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $2.00 | N/A |
| AVG Volume (30 Days) | ★ 137.4K | 22.0K |
| Earning Date | 11-12-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $39,316,403.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 11.62 |
| 52 Week Low | $1.00 | $0.71 |
| 52 Week High | $1.55 | $2.58 |
| Indicator | ANTX | AACG |
|---|---|---|
| Relative Strength Index (RSI) | 48.13 | 63.67 |
| Support Level | $1.15 | $1.07 |
| Resistance Level | $1.28 | $1.17 |
| Average True Range (ATR) | 0.08 | 0.09 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 13.71 | 58.67 |
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.
ATA Creativity Global is an international educational services company focused on providing quality learning experiences that cultivate and enhance students' creativity. The operating segments of the company are (i) Overseas art study services (ii) Other educational services and (iii) Other services. Majority of its revenue comes from Overseas art study services.